Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer
Summary. At present, there are no valid prognostic biomarkers in patients with triple negative breast cancer (TNBC) except well known clinical factors such as tumor size, lymph node status, differentiation grade and proliferation rate. Aim: To evaluate the prognostic role of androgen receptor (AR) e...
Saved in:
| Date: | 2023 |
|---|---|
| Main Authors: | Lyalkin, S.A., Verevkina, N.O., Alekseyenko, O.O., Syvak, L.A. |
| Format: | Article |
| Language: | English |
| Published: |
PH Akademperiodyka
2023
|
| Subjects: | |
| Online Access: | https://exp-oncology.com.ua/index.php/Exp/article/view/2020-2-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Experimental Oncology |
Institution
Experimental OncologySimilar Items
-
Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: Tsyhyka, D.Y., et al.
Published: (2013) -
Prognostic factors in metastatic gastric carcinoma
by: Ben Kridis, W., et al.
Published: (2023) -
Integral characteristic of the immune system state predicts breast cancer outcome
by: Stakheyeva, M., et al.
Published: (2023) -
Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023) -
Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer
by: Kovalev, A.A., et al.
Published: (2013)